MIT study reveals how specific cells in AD become vulnerable and resilient
The neurodegenerative condition is recognised as the most common form of dementia
Read More
Tag: Dementia
Innovate UK grants £4m to four companies to evaluate biomarkers for dementia
The progressive neurodegenerative disease affects more than 55 million people globally
Read More
UK DRI and NHS collaborate on digitally enabled dementia care platform
Around one in five dementia hospitalisations are due to potentially preventable causes
Read More
Institutions to lead £1.7m-funded network to support people at risk of dementia
The neurodegenerative condition currently affects more than 944,000 people in the UK
Read More
Study reveals cardiovascular health could be biggest risk factor for dementia
Dementias, including Alzheimer’s disease, are estimated to affect 944,000 people in the UK
Read More
Researchers reveal how a protein interaction can increase Alzheimer’s risk
AD is the most common form of dementia, which affects over 944,000 people in the UK
Read More
UK dementia organisations publish new manifesto ahead of general election
The manifesto calls on the next UK government to make dementia a key health priority
Read More
Study links dementia antipsychotics to higher risks of serious health outcomes
The neurodegenerative condition currently affects more than 944,000 people living in the UK
Read More
Researchers suggest form of Alzheimer’s is transmissible via bone marrow transplants
The progressive neurodegenerative disease is estimated to affect 24 million people globally
Read More
Innovate UK awards ten projects over £6m to develop new clinical tools for dementia
Dementia is estimated to affect 850,000 people in the UK and costs the nation around £23bn a year
Read More
New study reveals neurological conditions as leading cause of ill health worldwide
In 2021, neurological conditions, including Alzheimer’s disease, affected approximately 3.4 billion people globally
Read More
Roche partners with Cardiff researchers to uncover new research into dementia
Affecting 55 million people globally, dementia impairs the ability to remember, think or make decisions
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
